Free Trial

DuPont de Nemours (DD) Stock Forecast & Price Target

DuPont de Nemours logo
$78.76 +0.61 (+0.79%)
As of 11:08 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DuPont de Nemours - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
10

Based on 12 Wall Street analysts who have issued ratings for DuPont de Nemours in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 2 have given a hold rating, and 10 have given a buy rating for DD.

Consensus Price Target

$99.17
25.90% Upside
According to the 12 analysts' twelve-month price targets for DuPont de Nemours, the average price target is $99.17. The highest price target for DD is $112.00, while the lowest price target for DD is $89.00. The average price target represents a forecasted upside of 25.90% from the current price of $78.76.
Get the Latest News and Ratings for DD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for DuPont de Nemours and its competitors.

Sign Up

DD Analyst Ratings Over Time

TypeCurrent Forecast
3/10/24 to 3/10/25
1 Month Ago
2/9/24 to 2/8/25
3 Months Ago
12/11/23 to 12/10/24
1 Year Ago
3/11/23 to 3/10/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
10 Buy rating(s)
9 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$99.17$98.00$95.42$75.67
Forecasted Upside25.90% Upside29.36% Upside16.29% Upside5.98% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Remove Ads

DD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

DuPont de Nemours Stock vs. The Competition

TypeDuPont de NemoursBasic Materials CompaniesS&P 500
Consensus Rating Score
2.83
2.76
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside26.80% Upside155.60% Upside16.54% Upside
News Sentiment Rating
Positive News

See Recent DD News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/25/2025UBS Group
4 of 5 stars
Joshua Spector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$102.00 ➝ $103.00+26.24%
2/13/2025Citigroup
3 of 5 stars
Patrick Cunningham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$88.00 ➝ $95.00+14.32%
2/13/2025BMO Capital Markets
4 of 5 stars
John McNulty
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$105.00 ➝ $112.00+34.97%
2/13/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Leithead
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$85.00 ➝ $89.00+8.83%
2/12/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Sison
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$107.00 ➝ $105.00+28.93%
2/10/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$104.00 ➝ $101.00+32.46%
1/17/2025Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Parkinson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$91.00+18.74%
1/15/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Stephen Tusa
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$104.00 ➝ $101.00+34.11%
10/21/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$88.00 ➝ $94.00+10.56%
8/1/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$92.00 ➝ $98.00+19.92%
5/23/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$83.00 ➝ $100.00+27.28%
5/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$78.00 ➝ $101.00+30.20%
1/16/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform$78.00 ➝ $80.00+5.92%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:08 AM ET.


Should I Buy DuPont de Nemours Stock? DD Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, March 2, 2025. Please send any questions or comments about these DuPont de Nemours pros and cons to contact@marketbeat.com.

DuPont de Nemours
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in DuPont de Nemours, Inc.:

  • Recent earnings report showed an EPS of $1.13, exceeding the consensus estimate of $0.98, indicating strong financial performance and potential for growth.
  • The company has increased its quarterly dividend to $0.41, reflecting a commitment to returning value to shareholders, with an annualized dividend yield of 2.01%.
  • Analysts have a consensus rating of "Moderate Buy" with a price target around $99.17, suggesting potential upside for investors based on current market conditions.
  • DuPont de Nemours, Inc. has a relatively low debt-to-equity ratio of 0.22, indicating a strong balance sheet and lower financial risk compared to peers.
  • The stock is currently trading around $81.25, which is within a reasonable range compared to its 52-week high of $90.06, presenting a potential buying opportunity.

DuPont de Nemours
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in DuPont de Nemours, Inc. for these reasons:

  • The P/E ratio of 48.89 suggests that the stock may be overvalued compared to its earnings, which could deter value-focused investors.
  • With a dividend payout ratio of 91.02%, there may be concerns about the sustainability of the dividend if earnings do not continue to grow.
  • The stock has a beta of 1.34, indicating higher volatility compared to the market, which may pose risks for conservative investors.
  • Despite recent positive earnings, the net margin of 5.47% indicates that profit margins are relatively thin, which could limit growth potential.
  • Analyst ratings show a mix of hold and buy ratings, suggesting uncertainty in the stock's future performance, which may be a red flag for some investors.

DD Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for DuPont de Nemours is $99.17, with a high forecast of $112.00 and a low forecast of $89.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DuPont de Nemours in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" DD shares.

According to analysts, DuPont de Nemours's stock has a predicted upside of 25.90% based on their 12-month stock forecasts.

Over the previous 90 days, DuPont de Nemours's stock had 2 upgrades by analysts.

DuPont de Nemours has been rated by research analysts at Barclays, BMO Capital Markets, Citigroup, JPMorgan Chase & Co., Royal Bank of Canada, UBS Group, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like DuPont de Nemours more than other "basic materials" companies. The consensus rating score for DuPont de Nemours is 2.83 while the average consensus rating score for "basic materials" companies is 2.76. Learn more on how DD compares to other companies.


This page (NYSE:DD) was last updated on 3/10/2025 by MarketBeat.com Staff
From Our Partners